Press Release · Cellenkos, Inc.
College of Medicine at Princess Nourah bint Abdulrahman University Signs Memorandum of Understanding with Cellenkos, Inc. to Advance Clinical Trials and Cell and Gene Therapies
Distributed by Economy Life · Originally issued via PR Newswire
PNU and Cellenkos sign MOU to advance education and training focused on clinical trials and CAGT
HOUSTON, Nov. 9, 2026 — Cellenkos Inc., a clinical stage biotechnology company, is pleased to share that The College of Medicine at Princess Nourah bint Abdulrahman University has signed a Memorandum of Understanding (MoU) with Cellenkos, Inc. to strengthen collaboration in clinical trials, cell and gene therapies, biomanufacturing technologies, and other areas of mutual interest.
The collaboration encompasses curriculum design, the training program development, virtual training sessions, live seminars, and workshops focused on clinical trials. It also provides opportunities to train students in scientific research. The College of Medicine was represented at the signing by its Dean, Dr. Reem AlHarbi, while Cellenkos, Inc. was represented by its Chief Operating Officer, Ms. Tara Sadeghi.
The Memorandum of Understanding (MoU) aims to achieve the shared objectives of both parties to strengthen international partnerships in education, training, and scientific research; develop qualified professionals in clinical trials and cell and gene therapies; and enhance communication and collaboration to support the development of human capabilities.
Cellenkos is thankful to Ministry of Investment, Saudi Arabia (MISA) for supporting this initiative. The MOU was signed at the Riyadh Global Medical Biotechnology Summit (RGMBS)/ Ministry of National Guard Health Affairs (MNGHA). Under the MOU, the inaugural workshop is planned to take place in the first quarter of year 2027.
Media contact: [email protected]
SOURCE Cellenkos, Inc.
About Cellenkos
Cellenkos is a clinical stage biotechnology company developing allogeneic tissue directed, cord blood derived T-regulatory cell therapies to resolve inflammation in autoimmune, neurodegenerative and inflammatory diseases. For more information: www.cellenkosinc.com
About Princess Nourah bint Abdulrahman University
PNU is the largest public women's university in the world, established in 1970. The university offers diplomas, bachelor and postgraduate degrees. It has 34 colleges in the city of Riyadh and in the neighboring cities, an Arabic Language Institute (for non-speakers of Arabic), a Deanship of Community Service and Continuous Education, and a Community College. It has more than 5,000 academic and administrative staff. For more information: https://pnu.edu.sa